AVEO Pharmaceuticals, Inc.
Charter Amendment in a 10-Q on 08/08/2019   Download
SEC Document
SEC Filing

 

 

 

 

 

 

 

 

 

 

State of Delaware

Secretary of State

Division of Corporations

Delivered 02:03 PM 05/28/2015

FILED 01:50 PM 05/28/2015

SRV 150805039 – 3444819 FILE

CERTIFICATE OF AMENDMENT

OF

RESTATED CERTIFICATE OF INCORPORATION

OF

AVEO PHARMACEUTICALS, INC.

Aveo Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows:

 

1.

The name of the Corporation is Aveo Pharmaceuticals, Inc.

 

2.

Article 4 of the Restated Certificate of Incorporation of the Corporation, is hereby amended by replacing the first paragraph thereof with the following:

“FOURTH: The total number of shares of all classes of stock which the Corporation shall have authority to issue is 205,000,000 shares, consisting of (i) 200,000,000 shares of Common Stock, $0.001 par value per share (“Common Stock”) and (ii) 5,000,000 shares of Preferred Stock, $0.001 par value per share (“Preferred Stock”).

 

3.

This Certificate of Amendment has been duly adopted by the Board of Directors and stockholders of the Corporation in accordance with Section 242 of the General Corporation Law of the State of Delaware.

 

4.

This Certificate of Amendment shall become effective at 5:00 p.m. Eastern Time on May 28, 2015.

IN WITNESS WHEREOF, the Corporation has caused its duly authorized officer to execute this Certificate of Amendment on this 28th day of May, 2015.

 

 

 

 

AVEO PHARMACEUTICALS, INC.

 

 

By:

 

/s/ Michael Bailey

Name:

 

Michael Bailey

Title:

 

President and Chief Executive Officer